Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $592.9800 (2.82%) ($592.9800 - $594.2650) on Tue. Oct. 26, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.67% (three month average) | RSI | 74 | Latest Price | $592.9800(2.82%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN advances 1.5% a day on average for past five trading days. | Weekly Trend | REGN advances 2.6% a week on average for past two weeks. | Market Behavior | Normal for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(53%) XLV(41%) DIA(39%) IWD(38%) SPY(37%) | Factors Impacting REGN price | REGN will decline at least -0.835% in a week (0% probabilities). VIXM(-21%) UUP(-7%) TBT(-7%) VXX(-5%) IGOV(-3%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.835% (StdDev 1.67%) | Hourly BBV | 1.9 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $574.74(3.17%) | 10 Day Moving Average | $563.42(5.25%) | 20 Day Moving Average | $562.53(5.41%) | To recent high | -13.3% | To recent low | 9.3% | Market Cap | $62.873b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |